{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:20:53Z","timestamp":1772842853688,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jiac.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T03:25:39Z","timestamp":1704511539000},"page":"785-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report"],"prefix":"10.1016","volume":"30","author":[{"given":"Kyoko","family":"Yokota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiro","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.01.002_bib1","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"p410","article-title":"Linezolid, tedizolid, and other oxazolidinones","author":"Heather","year":"2019"},{"key":"10.1016\/j.jiac.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jgar.2020.04.032","article-title":"Emerging erythromycin and clindamycin resistance in group a streptococci: efficacy of linezolid and tedizolid in experimental necrotizing infection","volume":"22","author":"Bryant","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2024.01.002_bib3","series-title":"Up to date","article-title":"Invasive group a streptococcal infection and toxic shock syndrome: treatment and prevention","author":"Stevens","year":"2023"},{"key":"10.1016\/j.jiac.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","article-title":"Effectiveness of adjunctive clindamycin in \u03b2-lactam antibiotic-treated patients with invasive \u03b2-haemolytic streptococcal infections in us hospitals: a retrospective multicentre cohort study","volume":"21","author":"Babiker","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.49.1.88-96.2005","article-title":"Effect of antibiotics on group a streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis","volume":"49","author":"Tanaka","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1473-3099(21)00456-4","article-title":"Increasing clindamycin resistance in group A streptococcus","volume":"21","author":"White","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","article-title":"High prevalence of macrolide-resistance and molecular characterization of streptococcus pyogenes isolates circulating in China from 2009 to 2016","volume":"8","author":"Lu","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2024.01.002_bib11","doi-asserted-by":"crossref","first-page":"e4592","DOI":"10.1093\/cid\/ciaa976","article-title":"Outcomes of \u03b2-hemolytic streptococcal necrotizing skin and soft-tissue infections and the impact of clindamycin resistance","volume":"73","author":"Horn","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib12","first-page":"269","article-title":"Clindamycin affects group A Streptococcus virulence factors and improves clinical outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/AAC.00804-09","article-title":"Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes","volume":"54","author":"Minami","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciac720","article-title":"Should linezolid replace clindamycin as the adjunctive antimicrobial of choice in group A streptococcal necrotizing soft tissue infection and toxic shock syndrome? A focused debate","volume":"76","author":"Cortes-Penfield","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/dkf192","article-title":"Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid","volume":"50","author":"Gemmell","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","article-title":"Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release","volume":"47","author":"Coyle","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.11150\/kansenshogakuzasshi1970.78.446","article-title":"[a case of invasive group a streptococcus infection which was successfully treated with linezolid]","volume":"78","author":"Nakamura","year":"2004","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2024.01.002_bib18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bjo.2006.090779","article-title":"Severe invasive beta haemolytic group a streptococcal cellulitis and eyelid necrosis treated with linezolid","volume":"90","author":"Barry","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jiac.2024.01.002_bib19","article-title":"Successful treatment of necrotizing fasciitis and streptococcal toxic shock syndrome with the addition of linezolid","volume":"2017","author":"Rac","year":"2017","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.jiac.2024.01.002_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1099\/jmm.0.000905","article-title":"Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus","volume":"68","author":"Katahira","year":"2019","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.jiac.2024.01.002_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02734-16","article-title":"Effects of tedizolid phosphate on survival outcomes and suppression of production of staphylococcal toxins in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia","volume":"61","author":"Le","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1128\/AAC.01565-10","article-title":"In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model","volume":"55","author":"Louie","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T19:39:18Z","timestamp":1731181158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1341321X24000047"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.01.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}